Latest Breaking News On - Pharma stock down - Page 4 : comparemela.com

Ocuphire Pharma, Inc (NASDAQ:OCUP) CFO Acquires $21,000 00 in Stock

Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Free Report) CFO Nirav S. Jhaveri purchased 10,000 shares of the company’s stock in a transaction on Thursday, March 21st. The shares were purchased at an average price of $2.10 per share, with a total value of $21,000.00. Following the completion of the purchase, the chief financial officer now […]

Niravs jhaveriOcuphire pharmaGeode capital managementRenaissance technologiesBlackrock incPrelude capital managementOcuphire pharma company profileAlliance global partnersShaughnessy asset managementOcuphire pharma incGet free reportPharma stock downCapital managementOcuphire pharma dailyNasdaq ocupInsider trading

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews com

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Pharma incEvoke pharmaFree reportPharma stock downGet free reportEvoke pharma daily

ABVC BioPharma, Inc (NASDAQ:ABVC) Sees Significant Decrease in Short Interest

ABVC BioPharma, Inc. (NASDAQ:ABVC – Get Free Report) was the recipient of a significant decrease in short interest during the month of January. As of January 31st, there was short interest totalling 124,000 shares, a decrease of 6.3% from the January 15th total of 132,400 shares. Based on an average daily volume of 2,470,000 shares, […]

United statesBiopharma incBiopharma company profileAbvc biopharma incExchange commissionVanguard group incGet free reportFree reportPharma stock downPharma companyPharma dailyAbvc biopharmaNasdaq abvc

Acasti Pharma (NASDAQ:ACST) Issues Quarterly Earnings Results, Beats Expectations By $0 02 EPS

Acasti Pharma (NASDAQ:ACST – Get Free Report) released its quarterly earnings results on Monday. The biopharmaceutical company reported ($0.21) EPS for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.02, MarketWatch Earnings reports. Acasti Pharma Stock Down 6.1 % Shares of Acasti Pharma stock opened at $2.45 on Wednesday. Acasti Pharma has a 1 […]

Acasti pharmaCraig hallumAcasti pharma incRenaissance technologiesAcasti pharma company profileGet free reportMarketwatch earningsPharma stock downFree reportPharma incAcasti pharma dailyNasdaq acst

Acasti Pharma (NASDAQ:ACST) Issues Earnings Results, Beats Expectations By $0 02 EPS

Acasti Pharma (NASDAQ:ACST) Issues Earnings Results, Beats Expectations By $0 02 EPS
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Craig hallumAcasti pharmaRenaissance technologiesAcasti pharma company profileAcasti pharma incExchange commissionGet free reportMarketwatch earningsPharma stock downFree reportPharma incAcasti pharma daily